Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Viatris Inc

VTRS ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Large Cap Analyst: BUY

Last Close

$16.61

▼ -1.60%

Market Cap $19.08B · Vol 1.77M

Key Metrics

P/E Ratio

N/A

FWD: 6.38

Market Cap

$19.08B

Large Cap

Div Yield

2.84%

Quarterly dividend

EPS Growth

+6.85%

YoY

RSI (14)

58.00

Momentum

Beta

0.87

vs Market

52W High

$18.38

9.63% below

52W Low

$9.43

76.23% above

Volume

1.77M

Avg 3.42M

P/B

0.97

Price-to-book

ROE

16.61%

Return on equity

Free Float

99.70%

Public shares

Shariah Compliance8 STANDARDS

✗ Viatris Inc (VTRS) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does VTRS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.61%

+1.10%

+4.27%

+17.30%

YTD

+33.41%

+58.49%

+64.29%

+14.16%

Financials & Valuation

TTM · Annual

Total Revenue	$14.30B
Net Income	$-3,514,900,000.00
Revenue Growth (YoY)	+4.88%
Gross Margin	39.55%
Operating Margin	8.63%
Net Profit Margin	-24.58%
ROE	16.61%
ROA · ROIC	-9.31% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	6.38
PEG Ratio	N/A
P/S	1.02
P/B	0.97
P/FCF	7.88
EPS Growth	+6.85%
Outstanding Shares	1.15B

Technical Indicators

50-Day SMA	$16.77
200-Day SMA	$14.75
RSI (14)	58.00
Beta	0.87
52-Week High	$18.38
52-Week Low	$9.43

Volume Today	1.77M
Avg Daily Volume (30D)	3.42M
Relative Volume	0.52x
Volatility (10D)	25.16
Volatility (30D)	28.94
Free Float	99.70%

Analyst Consensus

BUY

Current Price $16.61

Mean Target $18.16

52W Low$9.43 52W High$18.38

Current

Target

$9.43 $18.38

Current Analyst target

+9.33% upside potential · 11 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00Y52JV51

ISINUS92556V1061

CountryUnited States of America

Sub-IndustryPharmaceuticals (NEC)

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.21% JNJ Johnson & Johnson -2.22% ABBV Abbvie Inc -2.99% NVS Novartis AG -13.93% NOVN.S Novartis AG -10.89%

Company Profile

Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.